Indicators

Fate Therapeutics (NQ: FATE )

2.290 +0.220 (+10.63%)

Streaming Delayed Price Updated: 4:00 PM EST, Nov 22, 2024 Add to My Watchlist

Insider Filings

< Previous 1 2 3 4 Next >

Form 4

Source: SEC/Edgar

April 18, 2019

Form 4

Source: SEC/Edgar

March 28, 2019

Form 4

Source: SEC/Edgar

March 21, 2019

Form 3

Source: SEC/Edgar

March 17, 2019

Form 4

Source: SEC/Edgar

March 17, 2019

Form 4

Source: SEC/Edgar

March 04, 2019

Form 4

Source: SEC/Edgar

February 26, 2019

Form 4

Source: SEC/Edgar

January 31, 2019

Form 4

Source: SEC/Edgar

January 30, 2019

Form 4

Source: SEC/Edgar

January 29, 2019

Form 4

Source: SEC/Edgar

January 28, 2019

Form 4

Source: SEC/Edgar

January 22, 2019

Form 4

Source: SEC/Edgar

January 08, 2019

Form 4

Source: SEC/Edgar

January 08, 2019

Form 4

Source: SEC/Edgar

January 08, 2019

Form 4

Source: SEC/Edgar

January 08, 2019

Form 4

Source: SEC/Edgar

December 25, 2018

Form 4

Source: SEC/Edgar

December 20, 2018

Form 4

Source: SEC/Edgar

December 16, 2018

Form 4

Source: SEC/Edgar

December 13, 2018

Form 4

Source: SEC/Edgar

December 12, 2018

Form 4

Source: SEC/Edgar

September 26, 2018

Form 3

Source: SEC/Edgar

August 06, 2018

Form 4/A

Source: SEC/Edgar

August 02, 2018

Form 4

Source: SEC/Edgar

August 01, 2018

Form 4

Source: SEC/Edgar

August 01, 2018

Form 3

Source: SEC/Edgar

August 01, 2018

Form 3

Source: SEC/Edgar

August 01, 2018

Form 4

Source: SEC/Edgar

July 19, 2018

Form 4

Source: SEC/Edgar

May 15, 2018

< Previous 1 2 3 4 Next >

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.